The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s metabolomics market report forecasts the metabolomics market size to grow to $5.61 Billion by 2027, with a CAGR (compound annual growth rate) of more than 16%.

Learn More On The Metabolomics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report

Metabolomics Market Size Forecast
The global metabolomics market is expected to grow from $2.69 billion in 2022 to $3.09 billion in 2023 at a compound annual growth rate (CAGR) of 14.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global metabolomics market is expected to grow to $5.61 billion in 2027 at a CAGR of 16.1%.

North America held the largest metabolomics market share.

Key Metabolomics Market Driver ­– Increase In The Prevalence Rate Of Cancer
For instance, according to a report by WebMD, an American publisher of health related news, in 2021, 10 million people died of cancer worldwide. In 2020, according to the American Cancer Society, lung cancer is the leading cancer killer in both men and women in the USA, there were 228,820 new cancer cases and 135,720 deaths. Metabolomics approaches such as nuclear magnetic resonance (NMR) technique and mass spectrometry (MS) techniques have been used to study cancer. Companies like Metabolon Inc., Bruker Corp., and others have adopted metabolomics as a tool for early detection and cure for cancer.

Request for A Sample Of The Global Metabolomics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2497&type=smp

Key Metabolomics Market Trend – Adopting Machine Learning
Machine learning is increasing its popularity in the field of metabolomics due to improving efficiency in the interpretation of data generated from metabolomics techniques. Machine learning-enabled technologies help in the automation of risky and complex processes, avoid repetitive and time taking processes, provide quick and error-free services. Companies in the industry are preferring machine learning techniques for metabolism analysis to solve problems, automate processes and execute tasks. Some of the machine learning algorithms aid in metabolism data analysis and metabolic pathway modelling. Some of the companies such as Bio-Rad Laboratories, Metabolon Inc. and others have started using machine learning algorithms for better understanding and prediction in metabolomics study. For instance, MeltDB 2.0, a machine learning software used as a tool for the analysis and integration of metabolomics experiment data that aids research, store experimental data sets. Such machine learning software offer comprehensive analysis and visualization features for the proper representation of the large complex data.

Metabolomics Market Segment
1) By Product & Service: Metabolomics Instruments, Metabolomics Bioinformatics Tools & Services
2) By Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, Other Applications
3) By Indication: Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, Other Indications
4) By Metabolomics Instruments: Separation Techniques, Detection Techniques
5) By Metabolomics Bioinformatics Tools & Services: Bioinformatics Tools and Database, Bioinformatics Services

Metabolomics Market Major Players and Strategies
Major players in the metabolomics market are Human Metabolome Technologies, Metabolon, Bio-Rad Laboratories, Bruker, Agilent Technologies, Thermo Fisher, Waters, Biocrates Life Sciences, Shimadzu, Danaher Corporation, Kore Technologies Ltd., Dani Instruments S.P.A, Perkinelmer Inc., Evans Analytical Group LLC., LECO Corporation, Phenomenome Discoveries Inc., AB Sciex, BG Medicine Inc., Biomark Diagnostics Inc., Chenomx Inc., Creative Proteomics, Evotec A.G, and Merck kgaA. 3d.

The Metabolomics Global Market Report 2023 covers regional data on metabolomics market size, metabolomics market trends and drivers, opportunities, strategies, and metabolomics market competitor analysis. The countries covered in the metabolomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Metabolomics is a branch of bio-analytics that deals with the quantification and identification of metabolic small molecules found in cells, tissues, organs, and biological fluids.Research in the area of metabolomics focuses on the chemical reactions that metabolites go through.

View More Reports Related To The Metabolomics Market –
Bioinformatics Global Market Report 2023
Microbiome Global Market Report 2023
Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: